Your browser doesn't support javascript.
loading
Lenvatinib as a novel treatment for anaplastic thyroid cancer: A retrospective study.
Iwasaki, Hiroyuki; Yamazaki, Haruhiko; Takasaki, Hirotaka; Suganuma, Nobuyasu; Nakayama, Hirotaka; Toda, Soji; Masudo, Katsuhiko.
Afiliación
  • Iwasaki H; Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa 241-8515, Japan.
  • Yamazaki H; Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa 241-8515, Japan.
  • Takasaki H; Department of Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa 241-8515, Japan.
  • Suganuma N; Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa 241-8515, Japan.
  • Nakayama H; Department of Surgical Treatment, Yokohama City University Hospital, Yokohama, Kanagawa 236-0004, Japan.
  • Toda S; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Kanagawa 232-0024, Japan.
  • Masudo K; Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa 241-8515, Japan.
Oncol Lett ; 16(6): 7271-7277, 2018 Dec.
Article en En | MEDLINE | ID: mdl-30546466
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2018 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Año: 2018 Tipo del documento: Article País de afiliación: Japón